Bevacizumab, 1 mg

Bevacizumab is a recognized compound in chemical applications, featuring a molecular formula of C16H21NO3 and a molecular weight of 275.34. This compound belongs to a class of monoclonal antibodies, specifically designed to inhibit angiogenesis, a process essential for tumor growth. As such, it carries a Warning signal word due to potential harm if ingested. Bevacizumab exhibits high affinity for vascular endothelial growth factor A (VEGF-A), thereby preventing new blood vessel formation in various pathological conditions, including certain types of cancer. It also demonstrates low immunogenicity, making it suitable for long-term administration in therapeutic settings.

• CAS Number: 216974-75-3
• Molecular Formula: C16H21NO3
• GHS Signal Word: Warning
• Molecular Weight: 275.34
• Exact Mass: 275.15214353
• Hazard Statements:
• H302: Harmful if swallowed [Warning Acute toxicity, oral]